2) What is Fuchs Endothelial Corneal Dystrophy

A New Building for the Wilmer Eye Institute (view video)

Parking Changes at the Johns Hopkins Hospital

Wilmer Laser Vision Center

Clinician-Scientist Training Program

Support Wilmer using the new Online Giving Form
  

Julia Haller, professor of ophthalmology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration.

       

Powerpoint Podcast